NBR1 and pancreatic neoplasm: A recent study shows that NBR1 binds to MHC-I through its ubiquitin-binding domain and mediates the degradation of MHC-I molecules in autophagy lysosomes, thereby promoting immune evasion of pancreatic cancer.